Cargando…
Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials
BACKGROUND: An understanding of the health of potential volunteers in Africa is essential for the safe and efficient conduct of clinical trials, particularly for trials of preventive technologies such as vaccines that enroll healthy individuals. Clinical safety laboratory values used for screening,...
Autores principales: | Stevens, Wendy, Kamali, Anatoli, Karita, Etienne, Anzala, Omu, Sanders, Eduard J., Jaoko, Walter, Kaleebu, Pontiano, Mulenga, Joseph, Dally, Len, Fast, Pat, Gilmour, Jill, Farah, Bashir, Birungi, Josephine, Hughes, Peter, Manigart, Olivier, Stevens, Gwynn, Yates, Sarah, Thomson, Helen, von Lieven, Andrea, Krebs, Marietta, Price, Matt A., Stoll-Johnson, Lisa, Ketter, Nzeera |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2312327/ https://www.ncbi.nlm.nih.gov/pubmed/18446196 http://dx.doi.org/10.1371/journal.pone.0002043 |
Ejemplares similares
-
CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
por: Karita, Etienne, et al.
Publicado: (2009) -
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
por: Schmidt, C, et al.
Publicado: (2009) -
Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission
por: Kamali, Anatoli, et al.
Publicado: (2015) -
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020) -
Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa
por: Sanders, Eduard J., et al.
Publicado: (2017)